164 related articles for article (PubMed ID: 22311627)
1. Spotlight on respiratory viruses 2012: introduction.
de Jong MD; Hayden FG
Antivir Ther; 2012; 17(1 Pt B):131-2. PubMed ID: 22311627
[No Abstract] [Full Text] [Related]
2. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W
Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914
[TBL] [Abstract][Full Text] [Related]
3. New and emerging infectious diseases.
Spicuzza L; Spicuzza A; La Rosa M; Polosa R; Di Maria G
Allergy Asthma Proc; 2007; 28(1):28-34. PubMed ID: 17390754
[TBL] [Abstract][Full Text] [Related]
4. Implications of antiviral resistance of influenza viruses.
Monto AS
Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
[No Abstract] [Full Text] [Related]
5. Epidemic viral pneumonia.
Lapinsky SE
Curr Opin Infect Dis; 2010 Apr; 23(2):139-44. PubMed ID: 20087179
[TBL] [Abstract][Full Text] [Related]
6. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season.
Wkly Epidemiol Rec; 2011 Mar; 86(10):86-90. PubMed ID: 21395187
[No Abstract] [Full Text] [Related]
7. Simultaneous detection of SARS coronavirus and influenza A viruses using real-time polymerase chain reaction.
Seto WH
Hong Kong Med J; 2010; 16(5 Suppl 4):34-6. PubMed ID: 20864746
[No Abstract] [Full Text] [Related]
8. [Avian influenza and the Severe Acute Respiratory Syndrome (SARS) - experiences and perspectives].
Hoheisel G; Luk WK; Winkler J; Wirtz H; Gillissen A; Hui DS; Liebert UG
Pneumologie; 2007 Jan; 61(1):41-5. PubMed ID: 17253209
[TBL] [Abstract][Full Text] [Related]
9. Current and future antiviral therapy of severe seasonal and avian influenza.
Beigel J; Bray M
Antiviral Res; 2008 Apr; 78(1):91-102. PubMed ID: 18328578
[TBL] [Abstract][Full Text] [Related]
10. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
Barquera R; Collen E; Di D; Buhler S; Teixeira J; Llamas B; Nunes JM; Sanchez-Mazas A
HLA; 2020 Sep; 96(3):277-298. PubMed ID: 32475052
[TBL] [Abstract][Full Text] [Related]
11. Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season (northern hemisphere winter).
Wkly Epidemiol Rec; 2009 Feb; 84(9):65-72. PubMed ID: 19248288
[No Abstract] [Full Text] [Related]
12. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season.
Wkly Epidemiol Rec; 2016 Mar; 91(10):121-32. PubMed ID: 26971356
[No Abstract] [Full Text] [Related]
13. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.
Sakabe S; Iwatsuki-Horimoto K; Horimoto T; Nidom CA; Le Mt; Takano R; Kubota-Koketsu R; Okuno Y; Ozawa M; Kawaoka Y
Antiviral Res; 2010 Dec; 88(3):249-55. PubMed ID: 20849879
[TBL] [Abstract][Full Text] [Related]
14. Human cases of influenza at the human-animal interface, January 2015–April 2017.
Wkly Epidemiol Rec; 2017 Aug; 92(33):460-75. PubMed ID: 28819964
[No Abstract] [Full Text] [Related]
15. Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies.
Vigil A; Frias-Staheli N; Carabeo T; Wittekind M
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847855
[TBL] [Abstract][Full Text] [Related]
16. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
17. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
[TBL] [Abstract][Full Text] [Related]
18. Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China.
Ma Y; Feng Y; Liu D; Gao GF
Philos Trans R Soc Lond B Biol Sci; 2009 Sep; 364(1530):2725-37. PubMed ID: 19687041
[TBL] [Abstract][Full Text] [Related]
19. HHS-CDC NEWS: update: influenza activity--US and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine.
Ann Pharmacother; 2006; 40(7-8):1499-500. PubMed ID: 16849615
[No Abstract] [Full Text] [Related]
20. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Wu Z; Harrich D; Li Z; Hu D; Li D
Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
